专利检索 ap:("Phosimmune, INC." OR "The Board of Regents of the University of Oklahoma") AND inv:"Oriana E. Hawkins" 第 1 页

1.

发明申请
IDENTIFICATION OF MHC CLASS I PHOSPHO-PEPTIDE ANTIGENS FROM BREAST CANCER UTILIZING SHLA TECHNOLOGY AND COMPLEMENTARY ENRICHMENT STRATEGIES 审中-公开
标题翻译：通过使用SHLA技术和补充性培养策略确定来自乳腺癌的MHC一级磷酸肽抗原的鉴定

公开(公告)号：US20150225456A1

公开(公告)日：2015-08-13

申请号：US14403350

申请日：2013-05-28

申请人： Phosimmune, INC. , The Board of Regents of the University of Oklahoma

发明人： Donald F. Hunt , Andrew Norris , Ann Michelle English , Jeffrey Shabanowitz , William H. Hilderbrand , Oriana E. Hawkins

IPC分类号： C07K7/08 , A61K39/00 , C07K16/18 , C07K7/06

CPC分类号： C07K7/08 , A61K38/00 , A61K39/0011 , C07K7/06 , C07K14/4748 , C07K16/18 , C07K2317/24 , C07K2317/55

摘要： The present invention describes novel tumor-specific phosphorylated peptides, nucleic acids encoding those peptides, and antibodies generated against said peptides. The genes, peptides, and antibodies described herein may be used as diagnostic indicators of the presence of breast cancer and/or used in therapeutics to treat breast cancer.

摘要翻译： 本发明描述了新的肿瘤特异性磷酸化肽，编码这些肽的核酸和针对所述肽产生的抗体。本文所述的基因，肽和抗体可用作乳腺癌存在和/或用于治疗乳腺癌的诊断指标。

2.

发明授权
Identification of MHC class I phospho-peptide antigens from breast cancer utilizing SHLA technology and complementary enrichment strategies 有权

公开(公告)号：US11414458B2

公开(公告)日：2022-08-16

申请号：US16806374

申请日：2020-03-02

申请人： Agenus Inc. , The Board of Regents of the University of Oklahoma

发明人： Donald F. Hunt , Andrew Norris , Ann Michelle English , Jeffrey Shabanowitz , William H. Hilderbrand , Oriana E. Hawkins

IPC分类号： C07K7/08 , C07K14/47 , A61K39/00 , C07K7/06 , C07K16/18 , A61K38/00

摘要： The present invention describes novel tumor-specific phosphorylated peptides, nucleic acids encoding those peptides, and antibodies generated against said peptides. The genes, peptides, and antibodies described herein may be used as diagnostic indicators of the presence of breast cancer and/or used in therapeutics to treat breast cancer.

3.

发明申请
IDENTIFICATION OF MHC CLASS I PHOSPHO-PEPTIDE ANTIGENS FROM BREAST CANCER UTILIZING SHLA TECHNOLOGY AND COMPLEMENTARY ENRICHMENT STRATEGIES 有权

公开(公告)号：US20230059301A1

公开(公告)日：2023-02-23

申请号：US17811546

申请日：2022-07-08

申请人： AGENUS INC. , The Board of Regents of the University of Oklahoma

发明人： Donald F. Hunt , Andrew Norris , Ann Michelle English , Jeffrey Shabanowitz , William H. Hildebrand , Oriana E. Hawkins

IPC分类号： C07K7/08 , C07K14/47 , A61K39/00 , C07K7/06 , C07K16/18

摘要： The present invention describes novel tumor-specific phosphorylated peptides, nucleic acids encoding those peptides, and antibodies generated against said peptides. The genes, peptides, and antibodies described herein may be used as diagnostic indicators of the presence of breast cancer and/or used in therapeutics to treat breast cancer.